A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide

被引:85
作者
Mahesh, Koneti Venkata [1 ]
Singh, Sachin Kumar [1 ]
Gulati, Monica [1 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
关键词
Glipizide; Nanosuspensions; Liquid antisolvent precipitation; Media milling; Zeta potential; Particle size distribution d (90); DRUG-DELIVERY; NANOPARTICLES; FORMULATION;
D O I
10.1016/j.powtec.2014.02.011
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Glipizide nanosuspensions were prepared by both liquid antisolvent precipitation and media milling technique using bead mill. From this study it was concluded that ratio of polymer to drug, milling time and milling speed played significant role in controlling the zeta potential of nanosuspension prepared by media milling whereas, milling time and milling speed were considered to be significant factors for controlling particle size distribution d (90) of nanosuspension. In the bottom up process ratio of surfactant to drug and speed of mixing played a significant role in controlling the zeta potential of glipizide whereas ratio of polymer to drug and speed of mixing were considered to be the significant factors that affect the particle size distribution d (90) of nanosuspension. An increase in particle size distribution was observed with the optimized nanosuspension prepared by liquid antisolvent precipitation method when tested under accelerated conditions (40 degrees C at 75% RH for 6 months) as compared to media milling method. The X-ray diffraction data shows no form conversion of the drug due to processing parameters involved in the production of nanosuspension. The formulated nanosuspension has shown a faster dissolution profile (98.97 using bottom up and 96.44% using top down method in 10 min), relative to that of pure glipizide (20.17% in 10 min), mainly due to the formation of nanosized particles. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:436 / 449
页数:14
相关论文
共 21 条
[1]  
[Anonymous], 1996, The pharmacological basis of therapeutics
[2]   Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) :67-75
[3]   Current strategies for engineering drug nanoparticles [J].
Date, AA ;
Patravale, VB .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2004, 9 (3-4) :222-235
[4]   The effects of milling on the surface properties of form i paracetamol crystals [J].
Heng, Jerry Y. Y. ;
Thielmann, Frank ;
Williams, Daryl R. .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1918-1927
[5]  
HUTTENRAUCH R, 1985, PHARM RES-DORDR, P302, DOI 10.1023/A:1016397719020
[6]   Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension [J].
Kakran, M. ;
Sahoo, N. G. ;
Li, L. ;
Judeh, Z. ;
Wang, Y. ;
Chong, K. ;
Loh, L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 383 (1-2) :285-292
[7]   Nanosizing - Oral formulation development and biopharmaceutical evaluation [J].
Kesisoglou, Filippos ;
Panmai, Santipharp ;
Wu, Yunhui .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :631-644
[8]   Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process [J].
Kim, Min-Soo ;
Jin, Shun-Ji ;
Kim, Jeong-Soo ;
Park, Hee Jun ;
Song, Ha-Seung ;
Neubert, Reinhard H. H. ;
Hwang, Sung-Joo .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (02) :454-465
[9]   Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future [J].
Muller, RH ;
Jacobs, C ;
Kayser, O .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :3-19
[10]  
Otoom S., 2001, International Journal of Pharmaceutical Medicine, V15, P117